Eosinophils generate brominating oxidants in allergen-induced asthma

Journal of Clinical Investigation

Volumn 105, Issue 10, 2000, Pages 1455-1463

  Wu, Weijia ^a,b   Samoszuk, Michael K ^c   Comhair, Suzy A A ^a   Thomassen, Mary Jane ^a   Farver, Carol F ^a   Dweik, Raed A ^a   Kavuru, Mani S ^a   Erzurum, Serpil C ^a   Hazen, Stanley L ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HALIDE; HYDROGEN PEROXIDE; MYELOPEROXIDASE; OXIDIZING AGENT; PEROXIDASE;

ALLERGIC ASTHMA; ARTICLE; BROMINATION; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HALOGENATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG LAVAGE; PATHOGENESIS; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION;

EID: 0034033812     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9702     Document Type: Article

References (67)

1. Klebanoff, S.J., Locksley, R.M. Jong, E.C., and Rosen, H. 1983. Oxidative response of phagocytes to parasite invasion. Ciba Found. Symp. 99:92-112.
2. Weiss, S.J., Test, S.T., Eckmann, C.M., Ross, D., and Regiania, S. 1986. Brominating oxidants generated by human eosinophils. Science. 234:200-203.
3. Mayeno, A.N., Curran, A.J., Roberts, R.L., and Foote, C.S. 1989. Eosinophils preferentially use bromide to generate halogenating agents. J. Biol. Chem. 264:5660-5668.
4. Agosti, J.M., et al. 1987. The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. J. Allergy Clin. Immunol. 79:496-504.
5. Gleich, GJ., Ottesen, E.A., Leiferman, K.M., and Ackerman, S.J. 1989. Eosinophils and human disease. Int. Arch. Allergy Appl. Immunol. 88:59-62.
6. Rothenberg, M.E. 1998. Eosinophilia. N. Engl. J. Med. 338:1592-1600.
7. Holt, P.G., Macaubas, C., Stumbles, P.A., and Sly, P.D. 1999. The role of allergy in the development of asthma. Nature. 402:B12-B17.
8. DeChatelet, L.R., et al. 1977. Oxidative metabolism of the human eosinophil. Blood. 50:525-535.
9. Slungaard, A., Vercellotti, G.M., Walker, G., Nelson, R.D., and Jacob, H.S. 1990. Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J. Exp. Med. 171:2025-2041.
10. Someya, A., Nishijima, K., Nunoi, H., Irie, S., and Nagaoka, I. 1997. Study on the superoxide-producing enzyme of eosinophils and neutrophils-comparison of the NADPH oxidase components. Arch. Biochem. Biophys. 345:207-213.
11. Jong, E.C., Henderson, W.R., and Klebanoff, S.J. 1980. Bactericidal activity of eosinophil peroxidase. J. Immunol. 124:1378-1382.
12. Jong, E.C., Mahmoud, A.A., and Klebanoff, S.J. 1981. Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J. Immunol. 126:468-471.
13. Slungaard, A., and Mahoney, J.R., Jr. 1991. Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis. J. Exp. Med. 173:117-126.
14. Klebanoff, S.J., Agosti, J.M., Jorg, A., and Waltersdorph, A.M. 1989. Comparative toxicity of the horse eosinophil peroxidase-H2O2-halide system and granule basic proteins. J. Immunol. 143:239-244.
15. Kazura, J.W., Fanning, M.M., Blumer, J.L., and Mahmoud, A.A. 1981. Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J. Clin. Invest. 67:93-102.
16. Samoszuk, M.K., Nguyen, V., Thomas, C., and Jacobson, D. 1994. Effects of sonicated eosinophils on the in vivo sensitivity of human lymphoma cells to glucose oxidase. Cancer Res. 54:2650-2653.
17. Carlson, M.G., Peterson, C.G., and Venge, P. 1985 Human eosinophil peroxidase: purification and characterization J. Immunol. 134:1875-1879.
18. Ten, R.M., Pease, L.R., McKean, D.J., Bell, M.P., and Gleich, G.J. 1989. Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J. Exp. Med. 169:1757-1769.
19. Sakamaki, K., Tomonaga, M., Tsukui, K., and Nagata, S. 1989. Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. J. Biol. Chem. 264:16828-16836.
20. Jong, E.C., and Klebanoff, S.J. 1980. Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system. J. Immunol. 124:1949-1953.
21. Weiss, S.J., Klein, R., Slivka, A., and Wei, M. 1982. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70:598-607.
22. Foote, G.S., Goyne, T.E., and Lehrer, R.I. 1983. Assessment of chlorination by human neutrophils. Nature. 301:715-716.
23. Hazen, S.L., Hsu, F.F., Mueller, D.M., Crowley, J.R., and Heinecke, J.W. 1996. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98:1283-1289.
24. Slungaard, A., and Mahoney, J.R., Jr. 1991. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity. J. Biol. Chem. 266:4903-4910.
25. Teitz, N.W. 1999. Drugs: therapeutic and toxic. In Teitz textbook of clinical chemistry. C.A. Burtis and E.R. Ashwood, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. p. 2216.
26. Hazen, S.L., Hsu, F.F., and Heinecke, J.W. 1996. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: a chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J. Biol. Chem. 271:1861-1867.
27. Thurau, A.M., Schyk U., Wolf, V., Krug, N., and Schauer, U. 1996. Identification of eosinophils by flow cytometry. Cytometry. 23:150-158.
28. Hansel, T.T., et al. 1989. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J. Immunol. Methods. 122:97-103.
29. van Dalen, C.J., Whitehouse, M.W., Winterbourn, C.C., and Kettle, A.J. 1997. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem. J. 327:487-492.
30. Babior, B.M., Kipnes, R.S., and Curnutte, J.T. 1973. Biological defense mechanism: the production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52:741-744.
31. Hazen, S.L., Crowley, J.R., Mueller, D.M., and Heinecke, J.W. 1997. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radic. Biol. Med. 23:909-916.
32. Hazen, S.L., and Heinecke, J.W. 1997. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:2075-2081.
33. Wu, W., Chen, Y., d'Avignon, A., and Hazen, S.L. 1999. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry. 38:3538-3548.
34. Heinecke, J.W., et al. 1999, Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods Enzymol. 300:124-144.
35. Thomassen, M.J., et al. 1999. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J. Allergy Clin. Immunol. 104:1174-1182.
36. National Heart, Lung, and Blood Institute. 1997. Expert panel report 2: guidelines for the diagnosis and management of asthma. National Institutes of Health. Bethesda, Maryland, USA. Publication no. 97-4051, pp. 1-86.
37. Hazen, S.L., Hsu, F.F., Gaut, J.R, Crowley, J.R., and Heinecke, J.W. 1999. Modification of proteins and lipids by myeloperoxidase-derived oxidants. Methods Enzymol. 300:88-105.
38. Fuerst, D.E., and Jannach, J.R. 1965. Autofluorescence of eosinophils: a bone marrow study. Nature. 205:1333-1335.
39. Weil, G.J., and Chused, T.M. 1981. Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood. 57:1099-1104.
40. Samoszuk, M.K., and Espinoza, F.P. 1987. Deposition of autofluorescent eosinophil granules in pathologic bone marrow biopsies. Blood. 70:597-599.
41. Bos, A.J., Wevet, R., Hamers, M.N., and Roos, D. 1981. Some enzymatic characteristics of eosinophil peroxidase from patients with eosinophilia and from healthy donors. Infect. Immun. 32:427-431.
42. Samoszuk, M.K., Lukes, R.J., and Nathwani, B. 1986. Extensive deposition of eosinophil peroxidase in Hodgkin's and non-Hodgkin's lymphomas. Am. J. Pathol. 125:426-429.
43. Sedgwick, J.B., et al. 1992. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J. Immunol. 149:3710-3718.
44. Smith, H.R., et al. 1992. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J. Allergy Clin. Immunol. 89:1076-1084.
45. Sanders, S.P., et al. 1995. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am. J. Respir. Crit. Care Med. 151:1725-1733.
46. Jarjour, N.N., et al. 1997. The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. Am J. Respir. Crit. Care Med. 155:1515-1521.
47. Teitz, N.W. 1999. Drugs: therapeutic and toxic. In Teitz textbook of clinical chemistry. C.A. Burtis and H.R. Ashwood, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. p. 1097.
48. Faulkner, D.J. 1998. Marine natural products. Nat. Prod. Rep. 15:113-158.
49. James, D.M., Kunze, H.B., and Faulkner, D.J. 1991. Two new brominated tyrosine derivatives from the sponge Druinella (Psammaplysilla) purpurea. J. Nat. Prod. 54:1137-1140.
50. Manthey, J.A., Hager, L.P., and McElvany, K.D. 1984. Protein brominarion by bromoperoxidase from Penicillus capitatus. Methods Enzymol. 107:439-445.
51. Beissner, R.S., Guilford, W.J., Coates, R.M., and Hager, L.P. 1981. Synthesis of brominated heptanones and bromoform by a bromoperoxidase of marine origin. Biochemistry. 20:3724-3731.
52. Carney, J.R., and Rinehart, K.L. 1995. Biosynthesis of brominated tyrosine metabolites by Aplysina fistularis. J. Nat. Prod. 58:971-985.
53. 3-antagonist from the marine sponge Verongula gigantea. J. Nat. Prod. 57:175-177.
54. Gunaseketa, S.P., and Cross, S.S. 1992. Fistularin 3 and 11-ketofistularin 3. Feline leukemia virus active bromotyrosine metabolites from the marine sponge Aplysina archeri. J. Nat. Prod. 55:509-512.
55. 2Br and some N-brominated ammo acids. In Water chlorination: environmental impact and health effects. R.L. Jolley, W.A. Brungs, R.B. Cumming, and V.A. Jacobs, editors. Ann Arbor Science Publishers Inc. Ann Arbor, Michigan, USA. 171-181.
56. Thomas, E.L., Bozeman, P.M. Jefferson, M.M., and King, C.C. 1995. Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromamines. J. Biol. Chem. 270:2906-2913.
57. Comhair, S.A., Bhathena, P., Dweik, R.A., Kavuru, M.S., and Erzurum, S.C. 2000. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet. 355:624.
58. Hazen, S.L., d'Avignon, A., Anderson, M.M., Hsu, F.F., and Heinecke, J.W. 1998. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize alpha-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem 273:4997-5005.
59. Kanofsky, J.R., Hoogland, H., Wever, R., and Weiss, S.J. 1988. Singlet oxygen production by human eosinophils. J. Biol. Chem. 263:9692-9696.
60. Kanofsky, J.R. 1989. Bromine derivatives of amino acids as intermediates in the peroxidase-catalyzed formation of singlet oxygen. Arch. Biochem. Biophys. 274:229-234.
61. Brottman, G.M., Regelmann, W.E., Slungaard, A., and Wangensteen, O.D. 1996. Effect of eosmophil peroxidase on airway epithelial permeability in the guinea pig. Pediatr. Pulmonol. 21:159-166.
62. Yoshikawa, S., Kayes, S.G., and Parker, J.C 1993. Eosinophils increase lung microvascular permeability via the peroxidase-hydrogen peroxide-halide system. Bronchoconstriction and vasoconstriction unaffected by eosinophil peroxidase inhibition. Am. Rev. Respir. Dis. 147:914-920.
63. Pretolani, M., et al. 1994. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am. J. Respir. Crit. Care Med. 149:1167-1174.
64. Hamann, K.J., et al. 1993. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis. Am. J. Physiol. 265:L301-L307.
65. Minnicozzi, M., Duran, W.N., Gleich, G.J., and Egan, R.W. 1994. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J. Immunol. 153:2664-2670.
66. Gundel, R.H., Letts, L.G., and Gleich, G.J. 1991. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J. Clin. Invest. 87:1470-1473.
67. McCord, T.J., et al. 1975. Synthesis and microbiological activities of some monohalogenated analogs of tyrosine. J. Med. Chem. 18:26-29.